Universe Pharmaceuticals Inc. (UPC) Earnings History
Annual and quarterly earnings data from 2018 to 2025
Loading earnings history...
UPC EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
UPC Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 35.3% | -16.3% | -20.6% |
| 2024 | 26.4% | -34.8% | -37.9% |
| 2023 | 31.9% | -10.9% | -19.1% |
| 2022 | 54.5% | -17.5% | -21.8% |
| 2021 | 52.8% | 28.3% | 23.6% |
Download Data
Export UPC earnings history in CSV or JSON format
Free sign-in required to download data
Universe Pharmaceuticals Inc. (UPC) Earnings Overview
As of May 8, 2026, Universe Pharmaceuticals Inc. (UPC) reported trailing twelve-month net income of -$12M, reflecting +26.5% year-over-year growth. The company earned $-22.01 per diluted share over the past four quarters, with a net profit margin of -20.6%.
Looking at the long-term picture, UPC's historical earnings data spans multiple years. The company achieved its highest annual net income of $11M in fiscal 2021.
Universe Pharmaceuticals Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including HCWB (-$8M net income, -14677.1% margin), XTLB (-$1M net income, -227.7% margin), NUVB (-$146M net income, -325.3% margin), UPC has outperformed on profitability metrics. Compare UPC vs HCWB →
UPC Earnings vs Peers
Earnings metrics vs comparable public companies
UPC Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$4M | +57.9% | -$3M | $-1055.75 | -20.6% | -16.3% |
| 2024 | -$9M | -41.6% | -$8M | $-1436.12 | -37.9% | -34.8% |
| 2023 | -$6M | +29.5% | -$4M | $-1040.53 | -19.1% | -10.9% |
| 2022 | -$9M | -177.2% | -$7M | $-1475.02 | -21.8% | -17.5% |
| 2021 | $11M | +49.8% | $14M | $2147.18 | 23.6% | 28.3% |
| 2020 | $8M | +0.1% | $10M | $1295.70 | 24.6% | 33.4% |
| 2019 | $8M | -0.7% | $10M | $1294.54 | 22.7% | 29.4% |
| 2018 | $8M | - | $10M | $1303.36 | 26.7% | 33.9% |
See UPC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs UPC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare UPC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonUPC — Frequently Asked Questions
Quick answers to the most common questions about buying UPC stock.
Is UPC growing earnings?
UPC EPS is $-22.01, with earnings growth accelerating to +26.5%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-12M.
What are UPC's profit margins?
Universe Pharmaceuticals Inc. net margin is -20.6%, with operating margin at -16.3%. Below-average margins reflect competitive or cost pressures.
How consistent are UPC's earnings?
UPC earnings data spans 2018-2025. The accelerating earnings trend is +26.5% YoY. Historical data enables comparison across business cycles.